Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Biowatch
Home
>
Biowatch
Samsung Bioepis Aflibercept Biosimilar Available for Sale in Europe
Samsung Bioepis announced on the 30th that it has signed a patent agreement and licensing contract with the original drug developer for the sale of...
01/29/2026, 23:42 ET
Dementia Injection Drug ‘Lecanemab’ Formulation and Dosage Diversification... Will It Compete with Oral Medications?
American Biogen and Japanese Eisai are moving quickly to change the formulation and dosage of the dementia treatment injection drug ‘Lecanemab...
01/29/2026, 04:48 ET
Samsung Bioepis Achieves Record Sales of 1.672 Trillion Won Last Year
Samsung Bioepis achieved its highest performance last year in terms of sales. Excluding short-term milestone revenues,...
01/26/2026, 05:30 ET
K-Toxins Heading to China... Will Hugel Be Followed After 5 Years in the Top 3?
Domestic botulinum toxin companies are racing towards the Chinese market. With Hugel, which entered China first,...
01/26/2026, 05:30 ET
Generic Drug Price Reduction: How Much Benefit Will It Bring to Patients?
These days, the pharmaceutical industry is focused on the topic of 'drug price reduction.
01/25/2026, 23:33 ET
SK Bioscience Accelerates Development of Next-Generation Zaire Ebola Vaccine
SK Bioscience is accelerating the development of the next-generation Ebola vaccine with funding support from the...
01/23/2026, 03:23 ET
Can We Break Through Chemotherapy Resistance? A New Target for Triple-Negative Breast Cancer Appears
Among breast cancers, ‘triple-negative breast cancer ’ is particularly challenging to treat.
01/23/2026, 02:46 ET
Pharmaceutical Industry Establishes Successive R&BD Subsidiaries... Is Yuhan Corporation Joining?
Yuhan Corporation recently announced plans to establish a specialized subsidiary for 'Research and Business Development...
01/22/2026, 19:11 ET
Capture the 0.02% Micro Signal in Blood...Bio Venture GraBis Challenging Early Cancer Diagnosis
“If you miss one tiny signal, you could lose a life (Missing one tiny signal Cost a Life).
01/21/2026, 21:19 ET
NVIDIA and Eli Lilly Establish 'AI Drug Research Institute' with Up to $1.4 Trillion Investment Over 5 Years
Semiconductor company NVIDIA is partnering with global pharmaceutical company Eli Lilly to establish an artificial...
01/12/2026, 14:28 ET
Previous
18
19
20
21
22
Next